NATIONAL DRUG SCREENING, INC.
MELBOURNE, FLORIDA

National Drug Screening, Inc., established on January 22, 2013, is a Florida-based company specializing in drug and alcohol testing services designed to ensure compliance with Department of Transportation (DOT) regulations. Operating from Melbourne, FL, this entity serves employers regulated by the DOT, providing peace of mind through safety-focused and compliant programs ready for audits. National Drug Screening offers comprehensive services crucial for maintaining regulatory adherence, addressing common uncertainties among local medical facilities about qualifying to provide these services. While many local practitioners are capable of collecting specimens, they often lack expertise in ensuring compliance with intricate DOT testing program regulations. The company distinguishes itself by coordinating various components required for comprehensive drug and alcohol testing programs. These include random selections, the preparation of Management Information System (MIS) reports, and facilitating services like urine collection, laboratory tests, Medical Review Services (MRO), Breath Alcohol Testing, and Substance Abuse Professional (SAP) evaluations through its role as a C/TPA (Third Party Administrator/Consortium). Under DOT categorizations, National Drug Screening supports industries such as those regulated by the Federal Railroad Administration, ensuring the drug-free compliance of roles like engineers, conductors, dispatchers, and other safety-sensitive positions. Employers are advised to partner with qualified service providers for their drug testing programs, utilizing agents ranging from policy consultants to laboratory analysts. National Drug Screening's strategic role encompasses managing different industry segments involving multiple participants. These range from facilities collecting specimens (such as medical clinics, hospitals, or TPA offices) to on-site rapid testing, though not compliant with all DOT, HHS, and certain state regulations for confirmatory lab tests. Additionally, it collaborates with Employee Assistance Program (EAP) providers for managing employee well-being issues. With a filing number of P13000009793 in the Florida Secretary of State records, and a Federal Employer Identification Number (FEIN) 46-3810508, National Drug Screening underscores its commitment to comprehensive management by supporting its clients through every facet needed for regulatory conformity. Their contact includes phone lines available at (866) 843-4545 and (888) 441-7071, with further information accessible via their website at nationaldrugscreening.com.